These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37484409)

  • 1.
    Zhang W; Ou L; Peng C; Sang S; Feng Z; Zou Y; Yuan Y; Li H; Zhang G; Yao M
    Heliyon; 2023 Jun; 9(6):e16798. PubMed ID: 37484409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sanguisorba officinalis L. suppresses 5-fluorouracil-sensitive and-resistant colorectal cancer growth and metastasis via inhibition of the Wnt/β-catenin pathway.
    Zhang W; Peng C; Yan J; Chen P; Jiang C; Sang S; Yuan Y; Hong Y; Yao M
    Phytomedicine; 2022 Jan; 94():153844. PubMed ID: 34785413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bioactive Compound from
    Zhang W; Peng C; Shen X; Yuan Y; Zhang W; Yang C; Yao M
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34202548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of
    Zhang W; Sang S; Peng C; Li GQ; Ou L; Feng Z; Zou Y; Yuan Y; Yao M
    Front Oncol; 2022; 12():807718. PubMed ID: 35646655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanguisorba officinalis L synergistically enhanced 5-fluorouracil cytotoxicity in colorectal cancer cells by promoting a reactive oxygen species-mediated, mitochondria-caspase-dependent apoptotic pathway.
    Liu MP; Liao M; Dai C; Chen JF; Yang CJ; Liu M; Chen ZG; Yao MC
    Sci Rep; 2016 Sep; 6():34245. PubMed ID: 27671231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hydroxysafflor yellow A inhibits proliferation, migration, and chemoresistance of colorectal cancer cells through Akt/mTOR-autophagy pathway].
    Wang L; Li F; Gu NN; Shen H; Han CL; Li KY; Yan RY; Wang J; Mi ZK
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):517-524. PubMed ID: 36725241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PI3K/Akt/mTOR Signaling Pathway Suppresses 5-Fluorouracil Resistance in Gastric Cancer.
    Xing Z; Gao Y; Shi Y; Gao Z; Liu C
    Mol Biotechnol; 2023 Nov; ():. PubMed ID: 37999920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
    Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
    Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1α signaling pathway.
    Sun LT; Zhang LY; Shan FY; Shen MH; Ruan SM
    Chin J Nat Med; 2021 Feb; 19(2):143-152. PubMed ID: 33641785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways.
    Su P; Ahmad B; Zou K; Zou L
    Onco Targets Ther; 2020; 13():5207-5222. PubMed ID: 32606741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells.
    Lv L; Liu HG; Dong SY; Yang F; Wang QX; Guo GL; Pan YF; Zhang XH
    Tumour Biol; 2016 Jul; 37(7):8811-24. PubMed ID: 26747179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
    Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K/Akt signaling axis.
    Chen H; Deng J; Hou TW; Shan YQ
    J Ethnopharmacol; 2024 May; 325():117907. PubMed ID: 38342156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
    Lin J; Feng J; Yang H; Yan Z; Li Q; Wei L; Lai Z; Jin Y; Peng J
    Oncol Rep; 2017 Oct; 38(4):2293-2300. PubMed ID: 28849113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK/MEK/ERK signal pathway in colorectal cancer.
    Yang K; Gao K; Hu G; Wen Y; Lin C; Li X
    Onco Targets Ther; 2016; 9():7285-7295. PubMed ID: 27942222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of circ_0004585 enhances the chemosensitivity of colorectal cancer cells to 5-fluorouracil via the miR-874-3p/CCND1 axis.
    Wang S; Cao J; Pei L
    Histol Histopathol; 2023 Jan; 38(1):99-112. PubMed ID: 35900059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECM1 regulates the resistance of colorectal cancer to 5-FU treatment by modulating apoptotic cell death and epithelial-mesenchymal transition induction.
    Long S; Wang J; Weng F; Pei Z; Zhou S; Sun G; Xiang D
    Front Pharmacol; 2022; 13():1005915. PubMed ID: 36408224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.